Defibrillators Market Outlook (2022-2033)

Increasing Prevalence of Cardiovascular Diseases and Sudden Cardiac Arrest

The increasing prevalence of cardiovascular diseases (CVD) and sudden cardiac arrest (SCA) on a global scale are major contributing factors to the growth of the defibrillators market, since they are two of the most prevalent causes of morbidity and mortality worldwide. These cardiovascular diseases include coronary artery disease, arrhythmia, and heart failure, which are all major contributors to the global burden of disease. Due to the increasing prevalence of risk factors for CVDs, such as: Hypertension, Diabetes, Obesity, Smoking, and Sedentary Lifestyle, the incidence of cardiac emergencies requiring rapid intervention has also increased dramatically. Defibrillators (including Automated External Defibrillators - AEDs, Implantable Cardioverter Defibrillators - ICDs, and Wearable Devices) provide a means of returning the heart to a normal rhythm in cases of life-threatening arrhythmia and thereby increase survival rates significantly. As populations around the world continue to age, this is generating increased demand for defibrillators as seniors are at greater risk for suffering from a cardiac event. As the result of this increased awareness, there has been also a significant increase in the distribution of Advanced Defibrillators in hospital, EMS systems, and public access sites (PADS). Additionally, many Governments are investing in public-access AED programs and enacting regulations requiring the installation of AEDs in the workplace, schools, and airports to provide enhanced market growth. The increase in the clinical requirement for defibrillators to meet the growing rate of cardiac emergencies is therefore a key factor supporting the ongoing growth of the Global Defibrillators Market.

Expansion of Public Access and Home-Based Defibrillation

Expanding Public Access Defibrillation (PAD) programs and the adoption of home-based defibrillators is a major opportunity in the defibrillator market. Individuals now have increased awareness of how to survive sudden cardiac arrest and as a result many governments, health care organizations and private companies are encouraging the placement of automated external defibrillators (AEDs) in public locations that see a lot of foot traffic (e.g., airports/aircraft, schools, shopping malls, sports facilities, etc.). This trend allows manufacturers to address a much larger and growing market than simply what can be found in hospitals and clinics. Furthermore, home-based defibrillators and wearable cardioverter-defibrillators are becoming more popular, especially with patients who have known cardiac issues, are at risk for arrhythmias, or are recovering from surgery. The introduction of new technologies has also made it possible for home-based users to access compact, lightweight, user-friendly devices with voice prompts, as well as wireless connectivity and integration with emergency response systems. Emerging markets in Asia Pacific, Latin America and the Middle East will provide opportunities for manufacturers to reach these markets as the prevalence of cardiovascular disease continues to rise and income levels rise. By focusing on Public Access programs, remote monitoring solutions, and building patient-friendly devices to be used in the home setting, manufacturers will have the ability to reach under-penetrated segments and improve the availability of services needed to provide early response, leading to ongoing growth of the global defibrillator market.

The "Defibrillators Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• Defibrillators market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Defibrillators market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Defibrillators market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Defibrillators market
• Detailed company profiles, including SWOT analysis

The geographical scope of the Defibrillators market report is divided into five regions: North America, Asia Pacific, Europe, Middle East and Africa, and South and Central America. The Defibrillators market in Asia Pacific is expected to grow significantly during the forecast period.

The Asia-Pacific Defibrillators market is segmented into China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh, and the Rest of Asia. The Asia Pacific defibrillator market is expanding rapidly due to the increasing incidence of CVD, SCA, and the development of the region’s healthcare infrastructure. Countries such as China, India, Japan and South Korea are seeing a rise in demand for both ICDs and external defibrillators as they have become aware of the increasing risk of heart disease associated with older populations, lifestyle changes and better understanding about early intervention with a heart attack. Increasingly, AEDs are being placed in public spaces, businesses and schools as part of government initiatives (e.g. health campaigns, emergency preparedness programs), thus driving growth in the market. Hospitals, cardiac clinics and emergency medical services are key players in this area. However, more and more patients at risk for sudden cardiac arrest are using defibrillators in the home and wearables are starting to penetrate this market as well. With the advancements in technology such as semi automatic and fully automatic AEDs, smaller portable devices, remote monitoring systems and app-based monitoring systems are making it easier to use, safer and more convenient for the user, thus providing motivation for even greater use of defibrillator products. Also, as healthcare spending increases and patient awareness rises and more facilities offer reimbursement options in emerging economies, this is creating a larger market for defibrillator products. As a result of the needs of clinical necessity, rising rates of cardiac diseases, and efforts to improve the rates of survival from a sudden cardiac event, the Asia Pacific Region provides an opportunity for healthcare manufacturers and providers to grow significantly.

• The report includes qualitative and quantitative data in the Defibrillators market across product type, technology, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the Defibrillators market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the Defibrillators market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the Defibrillators market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 10 cover Defibrillators market segments by product type, technology, end user, and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. They cover the market volume revenue forecast and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the Defibrillators market. Companies have been profiled on the basis of their key facts, business descriptions, products and services, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The Defibrillators market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the glucose monitoring devices market are:

• In September 2025, ZOLL, an Asahi Kasei company announced the Zenix, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, has received premarket approval (PMA) from the US Food and Drug Administration (FDA).
• In October 2024, the PLATINIUM implantable cardioverter defibrillators (ICD)-produced by MicroPort CRM Shanghai-MicroPort Soaring CRM (Shanghai) Co., Ltd.) an associated company of MicroPort CRM, received approval from China’s National Medical Products Administration (NMPA). This marks the first ICD manufactured in China to gain approval for market launch and is set to be officially commercialized within the country.
• In March 2024, Stryker launched and showcased two new products “LIFEPAK CR2 automated external defibrillator (AED) for cardiac care” and “Evacuation Chair” for emergency patient evacuation.